scorecardresearch
Add as a preferred source on Google
Monday, November 10, 2025
TopicSerum Institute India

Topic: Serum Institute India

After public spat, Bharat Biotech & SII jointly pledge smooth roll out of Covid vaccines

The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.

Serum Institute, Bharat Biotech, Cadila vaccines — sifting science from non-science

In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.

Respect govt decision to bar Covishield export, expect nod in March-April, says Serum CEO

Adar Poonawalla, CEO of Serum Institute of India, says the govt restrictions ‘will be eased out very soon once the most vulnerable population starts getting vaccinated’.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Oxford vaccine to cost Rs 219-292 to govt, double for private buyers, says Adar Poonawalla

The Serum Institute of India CEO said Covishield will be sold to the govt and Global Alliance for Vaccines and Immunization countries first and on the private market later.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

Everything we know about Covishield, one of 2 Covid vaccines likely to get nod for use in India

Covishield is Serum Institute of India’s version of the Oxford-AstraZeneca vaccine that had been in the works for several months.

Health Minister Vardhan launches India’s first indigenous pneumococcal vaccine Pneumosil

Pneumosil, developed by SII in collaboration with partners like Bill and Melinda Gates Foundation, will be available at an affordable price, the health ministry said.

Serum Institute has produced 40-50 million doses of Covishield vaccine, says Adar Poonawalla

The Serum Institute CEO also said the vaccine rollout is expected to be slow in the initial phase due to some logistics issues and is expected to pick up once things get sorted.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

On Camera

Moon madness has taken over modern dating. A waning crescent is the best time to ghost

Alongside buying into the grift that is dating apps, the girlies are also installing astrology apps like Astrotalk to investigate the same tired mystery—will he ever text back?

Africa’s blue economy is booming. What it can learn from Asia

Aquaculture is the fastest growing food sector in Africa, offering significant returns on investment for all involved and achieving the continent’s goals for food security, dignified livelihoods and economic growth.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.